Evaluation of Visual Acuity in Myopic Cataract Patients Using Trifocal Intraocular Lens

  • STATUS
    Recruiting
  • End date
    Jul 1, 2023
  • participants needed
    80
  • sponsor
    Aier School of Ophthalmology, Central South University
Updated on 21 June 2021
astigmatism
myopia
intraocular lens implantation
nuclear cataract

Summary

The PanOptix trifocal IOL is a new trifocal intraocular lens which is proved to provide good range of vision for distance, intermediate and near and good visual quality in cataract patients with normal axial length. But whether it can get the same visual quality in myopia is still unknown

Description

There are a few publications of multi-focal IOLs on Chinese patients with high myopia. From published papers, it is known that performance of multifocal IOLs is satisfied in myopic patients. However there is no publication to investigate PanOptix in moderate and high myopic patients. So it is imperative to demonstrate good performance of PanOptix in those special patients. The purpose of this study is to assess visual performance and patient satisfaction after the implantation of PanOptix in myopic patients.

Details
Condition lens implant, Cataract, near vision, myopic, Myopia, lens implantation, intraocular lens implantation, Intraocular Lens, Cataracts
Clinical Study IdentifierNCT04927117
SponsorAier School of Ophthalmology, Central South University
Last Modified on21 June 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Axial myopic patientsRefractive condition match the axial length after eliminate the nuclear cataract induced myopia factor
Corneal astigmatism <1.0D (IOL-Master 500/700, Carl Zeiss Meditec, Jena, Germany)
Eyes with pupil diameter>2.5 mm (Photopic) and<6 mm (Mesopic) (Pentacam HR, Oculus Optikgerate GmbH)
Eyes with angle kappa<0.50 mm (Pentacam HR)
Eyes with corneal spherical aberration<0.50 (Pentacam HR)

Exclusion Criteria

Irregular corneal astigmatism
Any retinal disease, macular disease(Including myopic MD and retinal diseases) could affect VA, glaucoma and other severe intraocular diseases
Moderate-severe dry eye
AmblyopiaBCDVA<0.7 before cataract appears
Patients having difficulties with examinations or 3 months' follow-up
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note